You_2021_FASEB.J_35_e21205

Reference

Title : CRISPR\/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase - You_2021_FASEB.J_35_e21205
Author(s) : You H , Mayer JU , Johnston RL , Sivakumaran H , Ranasinghe S , Rivera V , Kondrashova O , Koufariotis LT , Du X , Driguez P , French JD , Waddell N , Duke MG , Ittiprasert W , Mann VH , Brindley PJ , Jones MK , McManus DP
Ref : FASEB Journal , 35 :e21205 , 2021
Abstract : You_2021_FASEB.J_35_e21205
ESTHER : You_2021_FASEB.J_35_e21205
PubMedSearch : You_2021_FASEB.J_35_e21205
PubMedID: 33337558

Related information

Citations formats

You H, Mayer JU, Johnston RL, Sivakumaran H, Ranasinghe S, Rivera V, Kondrashova O, Koufariotis LT, Du X, Driguez P, French JD, Waddell N, Duke MG, Ittiprasert W, Mann VH, Brindley PJ, Jones MK, McManus DP (2021)
CRISPR\/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase
FASEB Journal 35 :e21205

You H, Mayer JU, Johnston RL, Sivakumaran H, Ranasinghe S, Rivera V, Kondrashova O, Koufariotis LT, Du X, Driguez P, French JD, Waddell N, Duke MG, Ittiprasert W, Mann VH, Brindley PJ, Jones MK, McManus DP (2021)
FASEB Journal 35 :e21205